• | home
  • | corporate
  • | investors
  • | products
  • | clinical trials
  • | partnering
  • | contact
TSX: HBP - NYSE Amex: HBP - Frankfurt: HBP

Klean-Prep™
  • | Product Overview
  • | Topical Interferon Alpha-2b
  • | DOS47
    • | L-DOS47
  • | Orthovisc®
  • | Monovisc®
  • | Normacol™
  • | Imunovir™
  • | Klean-Prep™

Klean-Prep™

Helix sells Klean-Prep in Canada via its drug distribution division Rivex Pharma. The product is used for bowel lavage / evacuation, primarily as a pre-treatment for colon examination in colorectal cancer screening.

The product is marketed in a convenient 1-litre container with 4 sachets of powder to be used for the preparation of solution for oral ingestion. Each sachet is reconstituted in 1-litre of water for a total dose of 4-litres. The product is a balanced mixture of polyethylene glycol and electrolytes which, when added to water, produces a clear, colourless, iso-osmotic drinking solution that facilitates the flushing of the digestive tract of all solid material.

Please consult your physician for detailed information regarding the Corporation’s products and their suitability for you, as well as for regulatory approval status of such products in your country.


Medical/Market Need

Colorectal screening is accomplished by physical and X-ray examination and by a process called colonoscopy. The colonoscopy procedure is performed by inserting a flexible tube into the colon with a light source to allow the physician to visualize the colon walls. If polyps are detected, they can be removed with little or no discomfort to the patient. The simplicity of the examination and the significant cure rate from early detection, has resulted in a growing number of colonoscopies being performed each year. The need for a clean colon is paramount to performing a successful colonoscopy procedure.

For more information about Rivex Pharma, please go to http://www.rivexpharma.com.

Helix distributes pharmaceutical and medical products in Canada to assist with the treatment and/or prevention of disease. The Corporation’s products are intended only for use in countries in which they have received regulatory approval under the direction of qualified health care professionals approved by government agencies in such countries.

Material on this website regarding the Corporation’s products is provided for information purposes only. Inclusion of products and information on this site does not imply any official medical advice, recommendation or warranty. Information provided is not a substitute for the advice of an appropriate health professional. This website can be accessed from countries around the world and may contain references to the Corporation’s products and programs that have not been granted regulatory approval in your country. Please consult your health care professional for detailed information regarding the Corporation’s products and their suitability for you, as well as for regulatory approval status of such products in your country.



  • | home
  • | site map
  • | privacy
  • | terms of use / disclaimers
  • | polski
  • | login
© Helix BioPharma Corp.